# Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-analysis-of-empagliflozin-in-comparison-to-sitagliptin-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Mafalda Ramos,V. Foos,Anastasia Ustyugova,Nikco Hau,Pranav Gandhi,Mark Lamotte |
| Citations | 36 |
| DOI | 10.1007/s13300-019-00701-3 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://link.springer.com/content/pdf/10.1007/s13300-019-00701-3.pdf |
| OpenAlex ID | https://openalex.org/W2979657646 |
| PMID | 31602601 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Pranav Gandhi](https://scholariq.org/researchers/pranav-gandhi/)

## Paper journal

- [Diabetes Therapy](https://scholariq.org/journals/diabetes-therapy/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.